Goldman Sachs’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Sell
100,609
-4,893
-5% -$9.83K ﹤0.01% 6161
2025
Q4
$274K Buy
105,502
+21,730
+26% +$59.4K ﹤0.01% 5906
2025
Q3
$251K Buy
83,772
+17,594
+27% +$62.8K ﹤0.01% 5851
2025
Q2
$266K Sell
66,178
-47,161
-42% -$174K ﹤0.01% 5508
2025
Q1
$377K Sell
113,339
-65,484
-37% -$312K ﹤0.01% 5356
2024
Q4
$1.11M Buy
178,823
+74,275
+71% +$432K ﹤0.01% 4754
2024
Q3
$583K Buy
104,548
+10,858
+12% +$72.5K ﹤0.01% 4963
2024
Q2
$700K Buy
93,690
+39,358
+72% +$243K ﹤0.01% 4641
2024
Q1
$315K Buy
54,332
+325
+0.6% +$1.63K ﹤0.01% 4949
2023
Q4
$267K Sell
54,007
-162
-0.3% -$835 ﹤0.01% 5052
2023
Q3
$277K Buy
54,169
+11,034
+26% +$65K ﹤0.01% 4924
2023
Q2
$292K Buy
43,135
+31,466
+270% +$187K ﹤0.01% 5022
2023
Q1
$72.2K Buy
+11,669
New +$52.3K ﹤0.01% 5500
2022
Q2
Sell
-624,360
Closed -$6.17M 6469
2022
Q1
$6.17M Hold
624,360
﹤0.01% 3155
2021
Q4
$6.12M Hold
624,360
﹤0.01% 3209
2021
Q3
$6.08M Hold
624,360
﹤0.01% 3189
2021
Q2
$6.04M Buy
+624,360
New +$6.13M ﹤0.01% 3169

Other funds holding BTMD

Goldman Sachs's BTMD Position: Q1 2026 in Review

Goldman Sachs reduced its Biote Corp (BTMD) stake by 4.6% in Q1 2026, selling an estimated $9.83K and leaving 100,609 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #6161.

Goldman Sachs first reported a position in BTMD in Q2 2021 and has held it in 17 quarters since. The position peaked at $6.17M in Q1 2022. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Goldman Sachs held 100,609 shares of Biote Corp worth $136K as of Q1 2026.
  • Goldman Sachs sold 4,893 Biote Corp shares in Q1 2026, an estimated $9.83K.
  • Biote Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6161 holding.
  • Goldman Sachs first reported a position in Biote Corp in Q2 2021 and has held it in 17 quarters since.
  • Goldman Sachs's Biote Corp position peaked at $6.17M in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.